Intracranial Pressure Monitoring After Elective Surgery: A Study of 514 Consecutive Patients

Constantini, S.; Cotev, Shamay; Rappaport, Z. H.; Pomeranz, Shlomo; Shalit, M. N.

doi:10.1007/978-3-642-73987-3_19

Cited by 6 publications

(11 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1,2,20,21 Patients with severe or moderate head trauma, coma due to subarachnoid or intracerebral hematoma, Reye's syndrome, and toxic metabolic encephalopathy are candidates for ICP monitoring. 2,4,6,8,9,19,[21][22][23] Patients with GCS scores 6 8 should be considered for this procedure. In our department, these patients undergo ICP monitoring routinely.…”

Section: Discussionmentioning

confidence: 99%

“…Upon admission to the hospital, the average GCS score was 7.2 ± 2.7 (range, [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15]. The leading causes of ICP monitoring were trauma (303/631, 48.1%) and intracerebral hemorrhage (170/631, 26.9%) ( Table 1).…”

Section: Patient Characteristicsmentioning

confidence: 99%

“…3 Monitoring ICP values in aggressively-treated head trauma and neurologic patients has been shown to improve recovery rates. [4][5][6][7] A variety of monitoring techniques and devices are available, each with advantages and disadvantages. [8][9][10][11][12] A ventricular catheter connected to an external strain gauge, the ''gold standard" of ICP monitoring, is the most common system.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Risk factors and complications of intracranial pressure monitoring with a fiberoptic device

Bekâr¹,

Doğan²,

Abaş³

et al. 2009

Journal of Clinical Neuroscience

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Section: Patient Characteristicsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Risk factors and complications of intracranial pressure monitoring with a fiberoptic device

Bekâr¹,

Doğan²,

Abaş³

et al. 2009

Journal of Clinical Neuroscience

View full text Add to dashboard Cite

“…This interpretation is based on several clinical observations. Symptoms develop rapidly from metastases in the brain compared with other sites because of its rigid encasement, relatively small size compared with other body cavities, and high sensitivity to increased intracranial pressure 17‐19. Until recently, because of the relative urgency in treating brain metastases, patients with these lesions were very limited in their treatment options 20‐22.…”

Section: Discussionmentioning

confidence: 99%

Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases

Taylor

Bekele

et al. 2009

Cancer

115

View full text Add to dashboard Cite

BACKGROUND: The staging system for non–small cell lung cancer (NSCLC) does not consider tumor burden or number of metastatic sites, although oligometastases are more favorable. METHODS: Using log‐rank testing, the authors analyzed overall survival (OS) in 1284 patients newly presenting with metastatic NSCLC by number of metastatic organ sites and the presence of brain metastases. RESULTS: OS for patients without brain metastases was found to be correlated with the number of metastatic sites (P = .0009). Brain metastases conferred an inferior OS (median of 7 months vs 9 months; 95% confidence interval, 7‐8 months vs 8‐10 months [P = .00,002]). To evaluate the influence of tumor burden on OS, the authors considered subsets of patients in whom the brain (n = 135) or lung (n = 137) was the solitary metastatic organ site. In patients with brain metastases, OS was found to be correlated inversely with the volume of all metastases or the largest lesion (hazards ratio, 1.04 or 1.03, respectively; P = .01). For patients with lung metastases, OS was better for those with a maximum tumor size below the median of 40 mm (P = .0004). CONCLUSIONS: Staging of NSCLC and clinical trial patient stratification should include quantitation of tumor burden. The prognostic impact of brain metastases is small and partly dependent on tumor volume, which indicates the need for aggressive therapy for patients with NSCLC brain metastasis and their inclusion in clinical trials. Cancer 2009. © 2009 American Cancer Society.

show abstract

“…According to the literature, the effect of elective tumor resection on cerebral autoregulation and CO2 reactivity may be different [4]. According to the previous literature, pre-operative cerebral auto-regulation was impaired in a significant number of patients with large supratentorial tumor size and midline shift more than 5 mm and was associated with post-operative impaired cerebral autoregulation during the first 24 hours after the surgery [15].…”

Section: Discussionmentioning

confidence: 99%

Accuracy of non-invasive intracranial pressure measurement

et al. 2012

View full text Add to dashboard Cite

AbstractNon-invasive measurement of intracranial pressure (ICP) reduces the complications and cost for both patient and health care systems. Improvement of non-invasive methods has led to development of systems for reproducing continuous, real-time non-invasive ICP signals. So far, non-invasive methods have been tailored for the patients with head trauma. We have used Schmidt’s auto-adaptive method to assess the accuracy of this method for patients after surgery for supratentorial brain tumors. Data from forty patients with the diagnosis of brain tumor operated from 2008 to 2010 were used to estimate the accuracy of Schmidt’s method in our patients. We obtained the model parameters from 30 recordings. We determined the ICP wave form for the remaining patients by both invasive and non-invasive techniques. In the test group, by invasive method, the mean ICP±2SD was 17.1 ± 6.6 mmHg and using non-invasive method, the mean ICP ± 2SD was 16.5 ± 5.4 mmHg. The calculated error was 4.6 mmHg using root mean square errors. The average Pearson correlation between the estimated and real waveforms was 0.92. We believe that application of this method is acceptable for post-operative assessment of ICP in brain tumor patients.

show abstract

Intracranial Pressure Monitoring After Elective Surgery: A Study of 514 Consecutive Patients

Cited by 6 publications

References 6 publications

Risk factors and complications of intracranial pressure monitoring with a fiberoptic device

Risk factors and complications of intracranial pressure monitoring with a fiberoptic device

Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases

Accuracy of non-invasive intracranial pressure measurement

Contact Info

Product

Resources

About